Filing Details

Accession Number:
0000059478-18-000192
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2018-07-27 13:58:22
Reporting Period:
2018-07-26
Accepted Time:
2018-07-27 13:58:22
Original Submission Date:
2018-07-27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
59478 Lilly Eli & Co LLY Pharmaceutical Preparations (2834) 350470950
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1173275 P Jackson Tai Lilly Corporate Center
Indianapolis IN 46285
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-07-26 2,168 $95.22 53,228 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This amendment is being filed to correctly report the footnote of the original Form 4 which was intended to be placed in column 4 Price.
  2. This transaction was executed in multiple trades at prices ranging from $95.00 to $95.40. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.